Administration, Cutaneous
"Administration, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of suitable drug dosage forms to the skin for either local or systemic effects.
Descriptor ID |
D000279
|
MeSH Number(s) |
E02.319.267.120.060
|
Concept/Terms |
Administration, Cutaneous- Administration, Cutaneous
- Cutaneous Administration, Drug
- Cutaneous Administrations, Drug
- Drug Administration, Cutaneous
- Administration, Cutaneous Drug
- Administrations, Cutaneous Drug
- Cutaneous Drug Administrations
- Drug Administrations, Cutaneous
- Cutaneous Drug Administration
- Dermal Administration
- Drug Administration, Dermal
- Skin Administration, Drug
- Drug Skin Administrations
- Skin Administrations, Drug
- Skin Drug Administration
- Skin Drug Administrations
- Administration, Dermal
- Administrations, Dermal
- Dermal Administrations
- Cutaneous Administration
- Administrations, Cutaneous
- Cutaneous Administrations
- Dermal Drug Administration
- Administration, Dermal Drug
- Administrations, Dermal Drug
- Dermal Drug Administrations
- Drug Administrations, Dermal
Administration, Transcutaneous- Administration, Transcutaneous
- Administrations, Transcutaneous
- Transcutaneous Administrations
- Administration, Transdermal
- Administrations, Transdermal
- Transdermal Administrations
- Transdermal Administration
- Transcutaneous Administration
Percutaneous Administration- Percutaneous Administration
- Administration, Percutaneous
- Administrations, Percutaneous
- Percutaneous Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Administration, Cutaneous".
This graph shows the total number of publications written about "Administration, Cutaneous" by people in this website by year, and whether "Administration, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 2 | 2 |
2005 | 0 | 1 | 1 |
2007 | 0 | 3 | 3 |
2008 | 0 | 4 | 4 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 0 | 4 | 4 |
2012 | 0 | 2 | 2 |
2015 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Cutaneous" by people in Profiles.
-
Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Therapeutic options. J Am Acad Dermatol. 2019 Sep; 81(3):669-680.
-
Spierings EL, Brandes JL, Kudrow DB, Weintraub J, Schmidt PC, Kellerman DJ, Tepper SJ. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine. Cephalalgia. 2018 02; 38(2):215-224.
-
Handley N, Unger A. Antibiotic Overuse and Paronychia: A Teachable Moment. JAMA Intern Med. 2016 Jan; 176(1):19-20.
-
Sutherland L, Laschinger M, Syed ZU, Gaspari A. Treatment of alopecia areata with topical sensitizers. Dermatitis. 2015 Jan-Feb; 26(1):26-31.
-
Ghasri P, Gattu S, Saedi N, Ganesan AK. Chemical leukoderma after the application of a transdermal methylphenidate patch. J Am Acad Dermatol. 2012 Jun; 66(6):e237-8.
-
Smith TR, Goldstein J, Singer R, Pugach N, Silberstein S, Pierce MW. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system. Headache. 2012 Apr; 52(4):612-24.
-
Rubenzik MK, Schwartz LR, Humphreys TR. Large facial basal cell carcinoma treated with multimodal combination therapy. Cutis. 2011 Oct; 88(4):182-4.
-
Tammaro A, Narcisi A, Persechino S, Caperchi C, Gaspari A. Topical and systemic therapies for nickel allergy. Dermatitis. 2011 Sep-Oct; 22(5):251-5.
-
Elia J, Wilson Z, La Porta LS, Algon SA, Prowler ML, Cartwright ST, McKenna PA, Laracy S, Takeda T, Borgmann-Winter K. Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder. Expert Rev Clin Pharmacol. 2011 May; 4(3):311-28.
-
Seder DB, Schmidt JM, Badjatia N, Fernandez L, Rincon F, Claassen J, Gordon E, Carrera E, Kurtz P, Lee K, Connolly ES, Mayer SA. Transdermal nicotine replacement therapy in cigarette smokers with acute subarachnoid hemorrhage. Neurocrit Care. 2011 Feb; 14(1):77-83.